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a b s t r a c t
The West Nile virus strain Kunjin virus (WNVKUN) NS4A protein is a multifunctional protein involved in
many aspects of the virus life-cycle and is a major component of the WNVKUN replication complex (RC).
Previously we identiﬁed a conserved region in the C-terminus of NS4A regulating proteolytic processing
and RC assembly, and now investigate key conserved residues in the N-terminus of NS4A and their
contribution to WNVKUN replication. Mutation of P13 completely ablated replication, whereas, mutation
of P48 and D49, near the ﬁrst transmembrane helix, and G66 within the helix, showed variable defects in
replication, virion secretion and membrane proliferation. Intriguingly, the P48 and G66 NS4A mutants
resulted in speciﬁc proteasome depletion of NS4A that could in part be rescued with a proteasome
inhibitor. Our results suggest that the N-terminus of NS4A contributes to correct folding and stability,
essential for facilitating the essential roles of NS4A during replication.
& 2015 Elsevier Inc. All rights reserved.
Introduction
West Nile virus strain Kunjin (WNVKUN) is an enveloped, posi-
tive sense RNA virus belonging to the Flaviviridae family, within the
Flavivirus genus. These viruses are typically vector-borne, and are
transmitted between their reservoir bird host and other species by
mosquitoes or ticks. Intracellular replication of WNVKUN and other
Flaviviruses occurs within the cytoplasm of infected cells, and is
typically associated with extensive proliferation and re-organisation
of intracellular membranes (Mackenzie, 2005). These membranes
have two proposed roles during replication; to protect replicative
components from detection by immune effectors, and to spatially
segregate viral RNA transcription from polyprotein expression and
processing, thus allowing more effective replication. WNVKUN induces
the formation of two distinct membrane compartments: the vesicle
packets (VP), which enclose the replicating RNA intermediates and
components of the replication complex (RC) (NS1, NS2A, NS3, NS4A
and NS5), and the convoluted membrane (CM)/ paracrystalline array
(PC) structures, which are the proposed sites of viral protein transla-
tion and proteolytic processing by the NS2B-3 protease (Mackenzie
et al., 2001;Westaway et al., 1997b). The source of thesemembranes is
thought to be the endoplasmic reticulum (ER), which is also the site of
virion assembly (Gillespie et al., 2010; Mackenzie and Westaway,
2001).
The small, hydrophobic proteins encoded by the Flaviviridae are
proposed to aid in the proliferation of intracellular membranes. An
example of this is NS4B from the Hepacivirus Hepatitis C virus, which
when individually expressed induces proliferation of the ER into
membranous webs, characteristic of those formed in infection
(Egger et al., 2002). Similarly, expression of the small hydrophobic
protein NS4A of WNVKUN and dengue virus (DENV) causes distinct
membrane proliferations similar to the CM/PC structures observed
during replication (Miller et al., 2007; Roosendaal et al., 2006).
Flavivirus NS4A is a 16 kDa, ER localised non-structural protein that
has three transmembrane helices, a membrane associated region and
a cytoplasmic N-terminus (Mackenzie et al., 1998; Miller et al., 2007).
In addition to its role in membrane proliferation, NS4A is also
predicted to form part of the WNVKUN RC, suggested from studies
which have shown interactions with the replicative intermediates
dsRNA, NS1, NS2A and NS5 as well as self-oligomerisation (Chu and
Westaway, 1992; Mackenzie et al., 1998). Based on topology studies, it
has been proposed that NS4A acts to anchor the complex to the VP
membranes by its transmembrane regions, whilst interacting with the
replicative components via its cytoplasmic N-terminus (Westaway
et al., 2002). Recent reports with DENV NS4A have identiﬁed an
amphipathic helix within the ﬁrst 20 residues of the cytoplasmic
domain, which when mutated reduced oligomerisation and
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intracellular replication (Stern et al., 2013). Additionally, this cytoplas-
mic region of NS4A has also been proposed to interact with the
cellular scaffolding protein vimentin (Teo and Chu, 2014), which is
required for efﬁcient replication. We and others have also shown that
NS4A plays a vital role in the regulation of cellular processes,
speciﬁcally stress responses (unfolded protein response and autop-
hagy signalling) and innate immune pathways (Ambrose and
Mackenzie, 2011b;
Lin et al., 2008; Liu et al., 2005; McLean et al., 2011; Munoz-Jordan
et al., 2003).
Our previous work in this ﬁeld has interrogated the role of
conserved residues of WNVKUN NS4A in its functions during intracel-
lular replication. Across the Flavivirus genus, NS4A is highly conserved,
particularly within the transmembrane regions. We identiﬁed a cons-
erved motif in the cytoplasmic loop between the last two transmem-
brane helices (Pro–Glu–Pro–Glu) which is vital forWNVKUN replication
and virion production (Ambrose and Mackenzie, 2011a). Mutation of
these residues resulted in loss of correct proteolytic processing of
NS4A, and associations with RC components, which we proposed was
the reason for replication attenuation. We were thus interested in
investigating other conserved regions within the N-terminal portion of
NS4A and whether they contributed to the function(s) of NS4A during
replication. A highly conserved proline in the ﬁrst 20 amino acids was
essential, as alanine substitution completely ablated all protein and
virus production. Two mutations (P48A and G66A) were highly atten-
uated and resulted in a speciﬁc, proteasome-mediated depletion of the
mutant NS4A proteins. This loss of expression also resulted in inefﬁ-
cient replication and decreased proliferation of a subset of virus-
induced membranes. However, restoration of NS4A levels by inhibi-
tion of the proteasome induced expansion of the ER, which we attri-
buted to increased expression of the membrane-inducing NS4A.
Results
N-terminal mutations differentially impair virus replication and
virion secretion
Previously we identiﬁed a conserved motif (Pro–Glu–Pro–Glu) in
the C-terminal cytoplasmic loop of NS4A, that is critical for proteolytic
processing at the NS4A-2K site and formation of the WNVKUN RC
(Ambrose and Mackenzie, 2011a). Extending those studies, we were
interested in investigating the importance of other conserved domains
in NS4A that function during WNVKUN replication. Based upon our
previously published alignment (Ambrose and Mackenzie, 2011a), see
also Supplementary Fig. 1, we identiﬁed 4 additional residues of
interest in the N-terminal half of NS4A; namely Pro13 in the cyto-
plasmic region, Pro48 and Asp49 at the junction between the
cytoplasmic and ﬁrst transmembrane helix regions, and a completely
conserved glycine (Gly66) in the middle of the ﬁrst transmembrane
helix. We generated point mutations in the WNVKUN infectious clone,
FLSDX, to change each residue separately to alanine (and to serine for
Gly66), then electroporated the transcribed RNA from each mutation
into Vero cells. RNA, protein lysates and t.c.f. samples were collected
and analysed at 24, 48 and 72 h.p.e. As shown in Fig. 1, the mutations
had variable effects on RNA replication, viral protein synthesis and
virion secretion. The P13A mutation was a lethal mutation, as
demonstrated by the absence of viral proteins or infectious virions
at all timepoints assayed. Low levels of WNVKUN genomic RNA were
detectable, however, as these did not increase over the timecourse
(Fig. 1A–C). P48A was severely attenuated, with signiﬁcant decreases
in genome replication (Fig. 1A–C), viral protein production (Fig. 1D–F)
and virion secretion (Fig. 1G) across all timepoints assayed. In
comparison, the neighbouring D49A mutation only caused mild
defects in replication, most notably at 24 h.p.e., and by later time-
points showed comparable levels of RNA, protein and virus production
to the WT samples. The glycine mutations (G66A and G66S) also
showed variable effects on replication; the alanine mutation was
highly attenuated, with reduced RNA, protein and virus production,
whilst the more conservative mutation to serine showed only
moderate effects similar to the D49A mutation. The plaque sizes of
secreted virions (Fig. 1H) also reﬂect these effects, with the more
attenuated P48A and G66A showing dramatically smaller plaques
compared to the milder effects of the D49A and G66S mutations.
However, of most interest was the dramatic difference in NS4A
protein levels between the various mutants. This was particularly
apparent at 48 h.p.e. (Fig. 1E); compared to the modest decreases in
NS5 levels in the P48A and G66A samples, the levels of NS4A were
markedly reduced whilst the less attenuated mutants showed a
similar NS4A and NS5 levels. This is especially signiﬁcant as all
WNVKUN proteins are translated from a single transcript, and thus
should all be expressed at a 1:1 ratio. However, when analysed by
densitometry (Fig. 1Eand F), we observed that in the more attenuated
mutants, the ratio of NS4A:NS5 (using actin as the loading control)
was drastically reduced (0.27 for the P48A mutant), although it should
be noted that these are arbitrary values derived from the western
blots without standards. These results suggest that the replication
defects observed in these mutants could be attributed to decreased
NS4A levels during early stages of replication.
N-terminal mutations partially affect replication but do not prevent
replication complex formation
To assess the effect of the Ala/Ser mutations (and associated
decreases in NS4A protein levels) on intracellular events of replication,
we analysed the associations of NS4A with the RC components NS1
(Fig. 2) and dsRNA (Fig. 3) by immunoﬂuorescence at 48 h.p.e. in all
mutants. As predicted from the qPCR and western data, no staining of
any viral component was observed in the P13A null mutant (data not
shown), and as such, this sample was excluded from further analysis.
The FLSDX WT-electroporated cells showed typical NS4A staining
(Fig. 2a), which co-localised with NS1 (Fig. 2b and c; Pearson's
coefﬁcient: Rr¼0.759) in a reticular pattern, with some larger
cytoplasmic foci. The D49A and G66S mutants (Fig. 2g–i and m–o)
showed a similar phenotype and equal levels of co-localisation with
NS1, which correlated with the near-WT levels of NS4A and replica-
tion at this timepoint (Pearson's coefﬁcient: Rr¼0.860 and Rr¼0.816,
respectively). As we had previously shown that NS4A is required for
RC formation, we hypothesised that the reduced expression levels of
mutant NS4A in the P48A and G66A samples would also result in loss
of RC associations with NS1. Both NS4A and NS1 staining in these
samples (Fig. 2d–f and j–l) were more diffuse and less reticular com-
pared to WT, however, colocalisation of NS4A with NS1 was reduced
but still apparent (Pearson's coefﬁcient: Rr¼0.683 and 0.698, respec-
tively). When we investigated the associations of NS4A and dsRNA
(Fig. 3), we observed a similar trend. NS4A colocalised with dsRNA in
all samples, although the phenotype differed slightly in the more
attenuated P48A and G66A samples (Fig. 3d–f and j–l). Interestingly,
the dsRNA staining signal also did not vary dramatically despite the
mutations made, indicating that only a small amount of NS4A (mutant
or WT) was necessary for RC formation and dsRNA production.
Overall, the combined data suggested that the mutations generated
in NS4A did not prevent intracellular replication but did result in an
overall decrease in efﬁciency.
Attenuated mutants show reduced intracellular membrane
proliferation
It has been observed that proliferation of intracellular membranes
coincides with the exponential increase inWNVKUN replication (Ng and
Hong, 1989), and that expression of NS4A alone is sufﬁcient to induce
CM/PC-like structures (Miller et al., 2007; Roosendaal et al., 2006).
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Thus, wewere interested in determining if themutations we generated
in NS4A could also affect its ability to remodel intracellular membranes.
To this end, we examined 50 nm thin sections from resin-embedded
samples collected at 72 h.p.e. for membrane formation. As shown in
Fig. 4, FLSDX WT-electroporated cells contained VPs as well as large
areas of CM and PC and virions within vesicles were also observed
(panels A and B). By visual comparison, the number and size of VPs in
the N-terminal mutants did not vary considerably (Fig. 4, panels C–F),
which correlated with the dsRNA staining in the previous ﬁgure.
However, the size of the CM/PC structures was radically reduced in
the P48A and G66A mutants (Fig. 4, panels C and E); in particular, no
CM/PC proliferations were detectable in any G66A-electroporated cells
and very few were observed in the P48A samples. This data suggested
that the overall decrease in NS4A protein levels in these mutants
(Fig. 1D–F) was most likely preventing CM/PC formation. Additionally,
the P48A mutant revealed large numbers of VP and virions (panel C),
Fig. 1. N-terminal mutations in WNVKUN NS4A differentially impair replication and virion production. Vero cells were electroporated with in-vitro synthesised FLSDX RNA
and protein lysates and cell culture supernatants were collected at 24, 48 and 72 h.p.e. (A–C) RNA collected from the various samples was quantiﬁed for WNVKUN genome
levels using qPCR. Error bars indicate þ1 standard deviation from triplicate experiments, and asterisks (**) indicate a signiﬁcant change compared to WT FLSDX as
determined by paired t-test (Graph Prism). (D–F) Protein lysates were analysed by western blot using antibodies raised against WNVKUN proteins NS4A and NS5, and the
internal control actin. Ratios shownwere determined by densitometry analyses compared to actin. (G) Cell culture supernatants were analysed by plaque assay for infectious
virion secretion and error bars (71 standard deviation) indicate duplicate analysis of triplicate experiments. (C) Visible plaques in the 105 dilution were analysed for size
difference after staining with toluidine blue.
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implying that the majority of available NS4A was utilised for the
formation of the RC and replication of the viral RNA.
Inhibition of proteasome-mediated degradation restores NS4A levels
but does not restore RNA replication or virion secretion
We were intrigued by the decreased NS4A levels in the P48A and
G66A samples (Fig. 1D–F), and hypothesised that the introduced
mutations caused speciﬁc degradation of the mutant NS4A proteins,
which would explain the discrepancies in NS4A:NS5 ratios. To address
this, we harvested t.c.f. samples from electroporated Vero cells at 72 h.
p.e. and re-infected Vero cells (m.o.i 0.1) with each of the mutant
viruses for 24 h, then treated infected cells for a further 24 h with
inhibitors of the proteasomal (Bortezomib) and the lysosomal (Chlor-
oquine) degradation pathways. We then assessed the levels of NS4A
by western blotting, compared to NS5 and the loading control actin.
As shown in Fig. 5A, treatment of cells with the 26S proteasome
inhibitor Bortezomib signiﬁcantly increased NS4A levels (compared to
untreated) in all the mutant samples as well as WT. Concomitantly,
NS5 levels did not overtly change, nor did the loading control actin,
suggesting this effect was limited to NS4A. Interestingly, a similar
proteasome inhibitor MG132 did not restore NS4A levels to that of
Bortezomib (data not shown) suggesting that the mutations generated
in NS4A resulted in increased targeting to the proteasome for ER-
associated degradation. In comparison, the lysosomal inhibitor Chlor-
oquine did not restore NS4A levels compared to untreated, suggesting
Fig. 2. N-terminal mutations decrease efﬁciency of replication but do not prevent replication complex formation. Vero cells were electroporated with in-vitro synthesised
FLSDX RNA, ﬁxed at 48 h.p.e. and labelled with antibodies to WNVKUN NS4A (red) and NS1 (green). Nuclei were counterstained with DAPI. Pearson coefﬁcient values (Rr)
shown were computed using ImageJ.
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that the degradation of mutant NS4A was mediated by the protea-
some. Intriguingly, we observed overall increases in WT as well as the
mutant NS4A proteins. Overall however, the restoration in NS4A levels
by Bortezomib was much more pronounced in the attenuated P48A
and G66A mutants, supporting our hypothesis that these mutations
are causing increased proteasomal degradation of NS4A and thus
reducing membrane proliferation and efﬁciency of replication.
We next attempted to investigate whether the Bortezomib-
mediated increases in NS4A levels could restore RNA replication
and/or virion secretion. To assess this, we collected RNA and super-
natants from re-infected cells treated with Bortezomib (or mock
treated with DMSO) and assayed for genome replication via qPCR
(Fig. 5B) and virus secretion by plaque assay (Fig. 5C). Intriguingly, we
did not observe any signiﬁcant differences between Bortezomib and
untreated samples with any of the WT or mutant viruses shown;
overall, modest decreases were observed in all samples by qPCR and
plaque assay analyses. Currently, we cannot completely explain the
lack of effect of restoring NS4A has onWNVKUN replication but suggest
that the effect of Bortezomib may be contributing to the other
functional roles of NS4A in modulating cellular and immune
responses. These are areas we are currently investigating.
Bortezomib restoration in NS4A levels results in expansion of the ER
We were also interested in investigating whether the increased
levels of NS4A in the attenuated mutants could rescue the ability of
Fig. 3. N-terminal mutations decrease efﬁciency of replication but do not prevent replication complex formation. Vero cells were electroporated with in-vitro synthesised
FLSDX RNA, ﬁxed at 48 h.p.e. and labelled with antibodies to WNVKUN NS4A (red) and the replicative intermediate dsRNA (green). Pearson coefﬁcient values (Rr) shownwere
computed using ImageJ.
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NS4A to remodel intracellular membranes. Thus, we compared NS4A,
NS3 and dsRNA labelling in FLSDX WT, P48A and G66A-infected cells
treated with Bortezomib (and untreated as a control). We observed
that Bortezomib treatment caused increased thickening of the peri-
nuclear region containing NS3, NS4A and dsRNA in all samples,
including WT (arrows depict the thickened ER in Fig. 6). We proposed
that this likely due to the increased proliferation of ER membranes,
due to higher expression of both WT and mutant NS4A. To address
this, we co-labelled infected cells with NS4A and NS3 as well as the
resident ER protein, protein disulphide isomerase (PDI; Fig. 7). PDI has
previously been shown to localise to WNVKUN-induced membrane
proliferations (Mackenzie and Westaway, 2001), and we obser-
ved signiﬁcant colocalisation between NS3, NS4A and PDI in the
Bortezomib-treated samples of FLSDX WT, P48A and G66A-infected
cells (Fig. 7). In all the samples, there was an obvious increase in
perinuclear staining of NS3 and NS4A (indicated by arrows) that
colocalised with PDI (panels d, h, l, p, t and x). This was not apparent
in mock-infected cells treated with Bortezomib (Fig. 8), discounting
the possibility that this thickening could be due to a non-speciﬁc
effect of the proteasome inhibitor itself.
Discussion
Flavivirus NS4A is a highly conserved, ER-localised transmembrane
protein with a number of functions in intracellular replication. We and
others have investigated various conserved regions within this protein
in order to further understand how it can perform its various roles in
membrane proliferation, RC formation and regulation of cell signalling
(Fig. 9) (Ambrose and Mackenzie, 2011a, b; Chang et al., 1999; Lin et al.,
2008; Liu et al., 2005; McLean et al., 2011; Stern et al., 2013; Teo and
Chu, 2014). Previously, we identiﬁed a conserved tetrapeptide motif in
the C-terminal cytoplasmic loop responsible for correct proteolytic
processing at the NS4A-2K site, which when mutated resulted in
Fig. 4. Attenuated NS4A mutants show reduced intracellular membrane proliferation and ER recruitment. Vero cells were electroporated with in-vitro synthesised FLSDX
RNA and ﬁxed at 72 h.p.e. then processed for EM analysis. WNVKUN-typical membrane structures paracrystalline arrays (PC) and convoluted membranes (CM) were observed
as well as immature virions (black arrows). Black scale bar indicates 200 nM.
R.L. Ambrose, J.M. Mackenzie / Virology 481 (2015) 95–106100
complete ablation of WNVKUN replication (Ambrose and Mackenzie,
2011a). To follow up on that study, we aimed to interrogate additional
conserved regions in the N-terminus of WNVKUN NS4A, which is
proposed to interact with other replicase components and alsomediate
homodimerisation in DENV (Stern et al., 2013). Four conserved residues
were selected for further study; Pro13 in the N-terminal cytoplasmic
region, and Pro48, Asp49 and Gly66 associated with the ﬁrst trans-
membrane helix (Fig. 9). These were mutated to alanine and/or serine
within the WNVKUN infectious clone, FLSDX, and assayed for effects on
replication and intracellular membrane proliferation, which are two of
the major functions of NS4A during WNVKUN infection.
We observed that mutation of the cytoplasmic Pro13 to alanine
(P13A) completely abolished WNVKUN replication and virion secretion
(Fig. 1). Perhaps this was not entirely unexpected; as NS4A is predicted
to interact with replicase components (NS5, NS3 and replicating RNA)
on the cytoplasmic face of the VP, it could be assumed that the
hydrophilic N-terminal region would most likely mediate these
associations. Thus, changes in this region could potentially have a
deleterious effect on replicase associations and RC formation during
early replication. Additionally, a recent study with DENV NS4A
identiﬁed an amphipathic helix within the ﬁrst 20 amino acids of
the N-terminal region, whichwhen disrupted reduced oligomerisation
and completely abolished replication (Stern et al., 2013). Speciﬁc
mutation of Pro13 to Ala within a DENV replicon also resulted in a
replication null mutant. Interestingly, another study of DENV NS4A
showed that the ﬁrst 50 amino acids (corresponding to the cytoplas-
mic N-terminal region) could also interact with vimentin, a cellular
protein associated with intermediate ﬁlaments. This association was
proposed to be vital in the formation of DENV RCs (Teo and Chu,
2014), however we were unable to show any association of vimentin
with the WNV RC (data not shown) implying there may be subtle
differences in host component utilisation by the WNV and DENV.
Overall, it could be proposed that the ﬁrst 50 cytoplasmic residues of
NS4A are vital for interaction with viral and cellular components, and
mutations within this region (e.g. P13A) have a severe effect on RC
formation and intracellular replication (Fig. 9).
The remaining mutations in the transmembrane region of WNV
KUN NS4A had variable effects on replication (Figs. 1 and 9). Two of the
FLSDX mutants (P48A and G66A) were highly attenuated, with
decreased viral protein synthesis and virion secretion, and also
displayed signiﬁcant defects in intracellular membrane proliferation.
The remaining mutants (D49A and G66S) did show some early
attenuation in protein and virus production, however at later time-
points had similar levels of replication and an intracellular phenotype
similar toWT. Interestingly, we observed a dramatic speciﬁc reduction
in the levels of NS4A only in the highly attenuated mutants when
compared to both NS5 and the internal loading control (Fig. 1A),
implying a selective loss or degradation of mutant NS4A during
replication. We proposed that the decreased NS4A levels could be
attributed to proteasomal degradation, and attempted to rescue this
by treating infected cells with inhibitors of both the lysosomal and
proteasomal degradation pathways. Treatment with the 26S subunit
inhibitor Bortezomib increased NS4A levels in all mutants as well as
WT (Fig. 5), although the increase was much more pronounced in the
P48A and G66A mutants. We suggest that these more severe muta-
tions in or near the ﬁrst transmembrane helix affected the folding
and/or membrane insertion into the ER, and thus were targeted for
ER-associated degradation. When we compared the effect of Bortezo-
mib on the two Glycine mutations generated (non-conservative G66A
vs. conservative G66S) it appeared to support a folding defect; the
increase in G66A NS4A levels upon proteasome inhibition is much
greater than in the equivalent G66S samples. Thus, maintaining helix
associations with the serine substitution are resulting in a more
stably-expressed protein and less attenuation at the level of virus
replication. Of course we cannot discount that proteasome inhibitor,
via BZ, may have other multiple consequences for virus replication,
apart from increasing NS4A levels.
Our observation that Bortezomib treatment increased NS4A levels
in WT, as well as mutant virus-infected cells is intriguing for multiple
reasons. Given the hydrophobic nature of NS4A and its high levels of
expression during replication, it could be proposed that a small pro-
portion of WT NS4A could be targeted to the proteasome for
Fig. 5. Inhibition of proteasome-mediated degradation restores NS4A levels but does not improve RNA replication or virion production. Vero cells were infected at an m.o.i.
of 0.1 with WT and mutant FLSDX viruses for 24 h, then treated with the chemical inhibitors (200 nM Bortezomib [BZ] or 1 μM Chloroquine [CQ]) for a further 24 h.
(A) Protein lysates were then collected and analysed by western blotting with antibodies to WNVKUN NS4A and NS5 and the internal control actin. (B) RNA samples from
mock, WT, P48A, D49A, G66A and G66S mock- or Bortezomib treated cells were analysed for WNVKUN genome levels using qPCR. Error bars indicate þ1 standard deviation
of triplicate experiments. (C) Supernatant samples as above were analysed for infectious particle secretion by plaque assay. Error bars indicate þ1 standard deviation of
triplicate experiments.
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degradation, particularly oligomers. Additionally, we and others have
shown that this very nature of NS4A is responsible for induction of
UPR signalling, speciﬁcally IRE-1 and ATF6 activation (Ambrose and
Mackenzie, 2011b), which are closely associated with ERAD via the
proteasome as well as ER membrane biogenesis. Therefore, treatment
with Bortezomib could also have partially restored all NS4A levels
which may have originally been targeted for proteasomal degradation.
Intriguingly, these overall increases in NS4A also caused a dramatic
change to ER morphology in all the samples assayed, regardless of
levels of replication (Fig. 7). Large perinuclear accumulations of NS4A
and NS3 (both of which localise to the ER and ER-derived CM/PC
structures) were observed, which also colocalised with the ER marker
PDI. Thus we suggest that the increased levels of NS4A caused hyper-
proliferation of the ER, similar to what is observed upon over-exp-
ression of WNVKUN NS4A alone (Roosendaal et al., 2006), that aids in
the development of the viral RC to promote efﬁcient replication. Our
results would indicate that the levels of NS4A are important for
replication most likely by contributing to membrane remodelling to
compartmentalise the replicative components, including those for
replication and assembly (Mackenzie andWestaway, 2001; Westaway
et al., 1997a).
Overall, we propose that the replication defects associated with
mutations in the ﬁrst transmembrane region can be attributed to the
misfolding and/or degradation of NS4A. The reduced protein levels of
the P48A and G66A mutants were then insufﬁcient for intracellular
membrane proliferation and CM/PC formation, however, still
Fig. 6. Bortezomib restoration in NS4A levels results in expansion of the ER. Vero cells were infected at an m.o.i. of 0.1 with WT and mutant FLSDX viruses for 24 h, then
treated with Bortezomib [BZ] for a further 24 h. Following ﬁxation, cells were labelled with antibodies to WNVKUN NS3 (green), NS4A (red) proteins and dsRNA (blue) and
viewed on a Zeiss confocal microscope. Arrows depict the thickened ER after BZ treatment.
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permitted RC associations and RNA replication, as demonstrated by
dsRNA staining. As the CM/PC structures are considered to be the sites
of protein translation and proteolytic processing during WNVKUN
replication (Mackenzie, 2005; Westaway et al., 1997b), this may
explain the decreased viral protein production at earlier timepoints
in these mutants compared to WT and the less-attenuated D49A and
G66A. As virion assembly also requires ER membranes, loss of ER
proliferation could potentially reduce the levels of secreted virions,
also observed in the more attenuated mutants.
In conclusion, we showed that mutations in the cytoplasmic region
of WNVKUN NS4A completely abolished replication, whilst changes to
the ﬁrst transmembrane helix caused increased degradation of NS4A
via the proteasome, which resulted in inefﬁcient replication and loss
of intracellular membrane proliferation. This data supports previous
studies that have identiﬁed the cytoplasmic N-terminus of NS4A as a
vital region for its function during replication. It also correlates with
previous observations that only low levels of NS4A are required for RC
associations and initiation of replication, however a higher, threshold
level is needed to induce the proliferation of CM/PC structures, loss of
which results in inefﬁcient replication and virion secretion (Fig. 9A).
Combining this informationwith our previous work on the proteolytic
processing of NS4A, and other published data, we can now attribute
speciﬁc regions of NS4A to functions during Flavivirus replication
(Fig. 9B), and the relative importance of these roles. The N-terminal,
Fig. 7. Bortezomib restoration in NS4A levels results in expansion of the ER. Vero cells were infected at an m.o.i. of 0.1 with WT and mutant FLSDX viruses for 24 h, then
treated with Bortezomib [BZ] for a further 24 h. Following ﬁxation, cells were labelled with antibodies to WNVKUN NS3 (green), NS4A (red) proteins and the host ER-resident
protein Protein Disulphide Isomerase (PDI; blue) and viewed on a Zeiss confocal microscope.
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cytoplasmic region is crucial to replication, for the interaction with
both viral and host components as well as oligomerisation. In
comparison, the amino acids near and in the ﬁrst transmembrane
helix are important for protein stability and potentially membrane
associations, which when mutated result in severe attenuation and
NS4A degradation. Overall, this data provides more information about
the contributions of NS4A to Flavivirus replication and identiﬁes
regions associated with these functions, which could be used for
antiviral targets in the future.
Materials and methods
Cells and antibodies
Vero cells were maintained in high-glucose DMEM (Life Technol-
ogies) supplemented with 5% Foetal Bovine Serum (FBS; Serum
Supreme, Lonza), 50 U/mL–50 mg/mL Penicillin/Streptomycin (Gibco)
and 200 mM Glutamax (Gibco). Mouse anti-NS5 and NS1 monoclonal
antibodies were a kind gift from Prof Roy Hall (University of Queens-
land). WNVKUN-speciﬁc rabbit anti-NS4A polyclonal antisera were
kindly provided by Prof Alexander Khromykh (University of Queens-
land) (Mackenzie et al., 1998; Westaway et al., 1997a) and goat anti-
NS3 polyclonal sera from Prof. Paul Young (University of Queensland).
Mouse anti-dsRNA (clone J2) and mouse anti-actin antibodies were
purchased from English & Scientiﬁc Consulting Bt. (Hungry) and Santa
Cruz Biotechnology respectively. Mouse anti-PDI antibody was pur-
chased from Abcam. Bortezomib and Chloroquine were sourced from
Sigma-Aldrich.
Site-directed mutagenesis of WNVKUN infectious clones and in vitro
transcription/electroporation
Alanine/Serine mutations were generated in the WNVKUN cDNA
infectious clone, FLSDX using site-directed mutagenesis (Stratagene)
(Khromykh et al., 1998) with the primers described in Supplementary
Table 1. FLSDX clones were linearised by XhoI and DNA puriﬁed using
phenol:chloroform extraction. RNA was transcribed from 0.5 μg of
each linearised clone using SP6 RNA polymerase (New England
Biolabs) and electroporated into Vero cells using the Neon electro-
poration system (Life Technologies) (21150 V pulses, 20 ms pulse
width, inﬁnite resistance) in 100 mL tips. Cells were recovered in
growth medium (2% FBS, 200 mMGlutamax) at room temperature for
5 min then plated out into 6- and 24-well plates. Cell lysates and
tissue culture ﬂuid (t.c.f) samples were collected at 24, 48 and 72 h
post-electroporation (h.p.e).
Mutant virus propagation and titre determination
Tissue culture ﬂuid (t.c.f.) samples were collected from electro-
porated cells and centrifuged at 5000 rpm for 5 min to pellet dead
Fig. 8. Vero cells were mock-infected for 24 h, then treated with Bortezomib [BZ] for a further 24 h. Following ﬁxation, cells were labelled with antibodies to WNVKUN NS3
(green), NS4A (red) proteins and the host ER-resident protein Protein Disulphide Isomerase (PDI; blue) and viewed on a Zeiss confocal microscope.
Fig. 9. Summary of current NS4A mutagenesis effects on WNVKUN replication. Our
current data investigating the effect of alanine/serine substitutions at various
conserved residues of NS4A is summarised in Fig. 8. (A) The effect of these
mutations on WNVKUN replication, RC associations, membrane proliferation and
NS4A protein levels is shown. Membrane induction and NS4A protein levels were
not determined (ND) for the null mutation P13A. (B) The combined information
from our studies into conserved regions of NS4A is shown in context with the
predicted topology of NS4A within the ER membrane. Amino acids in red denote
null mutants in FLSDX, blue residues indicate attenuated viruses and residues in
green have little or no effect on WNVKUN replication when mutated. Red arrows
show dibasic cleavage sites targeted by the NS2B-3 protease whilst the black arrow
indicates the signalase cleavage site. From this and other published studies we
predict that the N-terminal region of NS4A is vital for protein–protein interactions
between viral and cellular components, the ﬁrst transmembrane region maintains
protein stability and the ﬁnal cytoplasmic loop is necessary for correct protease site
presentation and cleavage by NS2B-3.
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cells and debris. Supernatants were then diluted 10-fold in DMEM
(101–106) and used to infect Vero cells previously seeded in DMEM
complete media in 6-well plates. Cells were infected with 250 μL of
stock dilutions (in duplicate) and incubated at 37 1C for 60 min. 2 mL
of a semi-solid overlay containing 0.3% w/v low-melting point agarose,
2.5% w/v FCS, P/S, Glx, HEPES and NaCO3 was added to cells and
solidiﬁed at 4 1C for 30 min. Cells were incubated at 37 1C for 4 days,
ﬁxed in 10% formalin (Sigma) for 1 h and stained in 0.4% crystal violet
(with 20% v/v methanol and PBS) at RT for 1 h. Plaques were manually
counted and plaque-forming units per ml (pfu/mL) calculated.
Immunoﬂuorescence analysis
Cells were ﬁxed with 4% w/v paraformaldehyde (PFA) in PBS at RT
for 10 min, then permeabilised (in 4% PFA/PBS) with 0.1% w/v TritonX-
100 at RT for 10 min. Cells were then quenched in 0.2 M Glycine at RT
for 7 min, and blocked for 15 min in 1% bovine serum albumin (BSA)/
PBS at RT. Following washes with PBS, cells were incubated with
primary antibodies in 1% BSA/PBS for 1 h at RT. Cells were washed
4 times in 0.2% BSA/PBS then incubated with species speciﬁc
secondary antibodies conjugated to either Alexa Fluor 647, 594 or
488 in 1% BSA/PBS at RT for 45 min. Cells were washed in 0.2% BSA/
PBS, then PBS followed by 5min incubation with 4 μg/ml DAPI to
counterstain the nuclei. Coverslips were mounted with Ultramount
(Fronine) and immunoﬂuorescent staining was visualised on a Zeiss
confocal microscope (LSM 700) and ﬁgures assembled using Adobe
PhotoshopTM.
Western blot analysis
Cells were washed once with PBS then lysed with SDS lysis buffer
(0.1% SDS, 0.5 mM EDTA, 10 mM Tris pH8.0, 150 mM NaCl) containing
protease inhibitors (Protease inhibitor cocktail III, Astral Scientiﬁc) and
pipetted multiple times to reduce viscosity. Lysates were loaded on a
12% Tris–glycine polyacrylamide gel and separated at 100 V for 2 h.
Separated proteins were transferred to Hi-Bond ECL nitrocellulose
membrane (Amersham) at 100 V for 75 min and blocked at RT in 5%
skim milk/TBS (Diploma) with 0.05% Tween (TBS-T). Following block-
ing, membranes were washed for 15 min in TBS-T then incubated
overnight in primary antibodies diluted in 5% BSA/TBS-T at 4 1C.
Membranes were washed in TBS-T three times then incubated with
species-speciﬁc secondary antibodies conjugated to either Alexa Fluor
488 or 647 at RT for 2 h. Following twowashes in TBS-T and one wash
in TBS, membranes were viewed on the PharosFX ﬂuorescent scanner
(Bio-Rad). Densitometry analyses were performed using the Quantity
One software (Bio-Rad) as indicated by manufacturers.
RNA extraction and qPCR analyses
Cells were lysed in Trizol Reagent (Life Technologies) and RNA
extracted as indicated by the manufacturers. 1 mg of total RNA was
treated with RQ1 DNase (Promega) at 37 1C for 30 min to remove any
contaminating cellular DNA, and cDNA generated with the Sensifast
cDNA synthesis kit (Bioline) using both oligo d(T) primers and random
hexamers. Gene-speciﬁc cDNAs were ampliﬁed using primers to the
WNVKUN genome and the internal control RPL13A (as previously
published (Ambrose and Mackenzie, 2011b)) with ITaq Universal Sybr
Green (Bio-Rad) on an MX3000 real-time PCR machine (Agilent). Fold
induction of the WNVKUN genome was calculated by comparing
threshold cycle values (CT) to the internal control RPL13A.
Resin thin sections for electron microscopy
Cells were ﬁxed with 3% w/v glutaraldehyde in 0.1 M cacodylate
buffer for 2 h at room temperature. Cells were then washed several
times in 0.1 M cacodylate buffer followed by ﬁxation with 1% OsO4 in
0.1 M cacodylate buffer for 1 h. After washing of the cells in 0.1 M
cacodylate buffer, specimens were dehydrated in graded acetones for
10–20min each. Subsequently, samples were inﬁltrated with EPON
resin and polymerised in moulds for 2 days at 60 1C. 50 nm thin
sections were cut on a Leica UC7 ultramicrotome using a Diatome
diamond knife and collected on formvar and carbon-coated copper
mesh grids. Before viewing in TF30 transmission electron microscope
cells were post-stained with 2% aqueous uranyl acetate (UA) and
Reynold's lead citrate.
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